Vestal Point Capital, LP CLDX — Celldex Therapeutics Inc

Ownership history in Vestal Point Capital, LP  ·  6 quarters on record

AI Ownership Summary

Vestal Point Capital, LP reported Celldex Therapeutics Inc (CLDX) in 6 quarterly 13F filings from 2024 Q4 through 2026 Q1. Peak portfolio weight reached 1.87% in 2025 Q2. The latest visible filing shows CLDX at 1.09% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CLDX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Vestal Point Capital, LP's position in Celldex Therapeutics Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CLDX was reported at 1.09% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.87% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CLDX stock page Vestal Point Capital, LP fund profile Vestal Point Capital, LP full holdings
How Vestal Point Capital, LP held CLDX — position size vs. price
% of Fund (quarterly)    CLDX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 1,224,165 +59,165 +5.1% 1.09% $38.8M 2026-05-15 $31.34
2025 Q4 REDUCED — — — 1,165,000 -40,000 -3.3% 1.08% $31.6M 2026-02-17 $22.94
2025 Q3 REDUCED 31.1% +0.6% ❌ 1,205,000 -545,000 -31.1% 1.41% $31.2M 2025-11-14 $25.55
2025 Q2 ADDED — — — 1,750,000 +1,551,354 +781.0% 1.87% $35.6M 2025-08-14 $24.94
2025 Q1 REDUCED 34.9% +12.1% ❌ 198,646 -106,354 -34.9% 0.26% $3.6M 2025-05-15 $20.10
2024 Q4 INITIATED — — — 305,000 — — 0.46% $7.7M 2025-02-14 $22.70

🏢 Other funds also holding CLDX

As of 2026 Q1 — sorted by position size

Kynam Capital Management, LP 3Y 11.43% Elmind Capital, LP 7.79% Commodore Capital LP 3Y 4.95% 5AM Venture Management, LLC 3Y 4.38% Rosalind Advisors, Inc. 4.21% SUPERSTRING CAPITAL MANAGEMENT LP 4.08% GordonMD Global Investments LP 3.76% Novo Holdings A/S 3Y 7Y 3.08% Eversept Partners, LP 3Y 7Y 2.99% TSP Capital Management Group, LLC 3Y 7Y 2.9%

FAQ About Vestal Point Capital, LP and CLDX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Vestal Point Capital, LP reported owning CLDX?

Vestal Point Capital, LP reported CLDX across 6 quarterly 13F filings, from 2024 Q4 through 2026 Q1.

What was the largest reported CLDX position in Vestal Point Capital, LP's portfolio?

The largest reported portfolio weight for CLDX was 1.87% in 2025 Q2.

What is the latest reported CLDX position on this page?

The most recent filing on this page is 2026 Q1, when Vestal Point Capital, LP reported 1,224,165 shares, equal to 1.09% of portfolio, with an estimated market value of $38.8M.

What does the chart on this CLDX ownership page compare?

The chart compares Vestal Point Capital, LP's quarterly CLDX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Vestal Point Capital, LP time their CLDX position?

Based on 13F filing dates vs. subsequent CLDX price moves, Vestal Point Capital, LP correctly timed 2 out of 5 reported position changes (40%). The annualised alpha on CLDX relative to SPY over the holding period was +9.7%.

← Back to Vestal Point Capital, LP Holdings